Correlation Between CP ALL and DOD Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CP ALL and DOD Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CP ALL and DOD Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CP ALL Public and DOD Biotech Public, you can compare the effects of market volatilities on CP ALL and DOD Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CP ALL with a short position of DOD Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of CP ALL and DOD Biotech.

Diversification Opportunities for CP ALL and DOD Biotech

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between CPALL and DOD is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding CP ALL Public and DOD Biotech Public in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DOD Biotech Public and CP ALL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CP ALL Public are associated (or correlated) with DOD Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DOD Biotech Public has no effect on the direction of CP ALL i.e., CP ALL and DOD Biotech go up and down completely randomly.

Pair Corralation between CP ALL and DOD Biotech

Assuming the 90 days trading horizon CP ALL Public is expected to generate 0.59 times more return on investment than DOD Biotech. However, CP ALL Public is 1.69 times less risky than DOD Biotech. It trades about -0.14 of its potential returns per unit of risk. DOD Biotech Public is currently generating about -0.44 per unit of risk. If you would invest  6,450  in CP ALL Public on September 15, 2024 and sell it today you would lose (200.00) from holding CP ALL Public or give up 3.1% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

CP ALL Public  vs.  DOD Biotech Public

 Performance 
       Timeline  
CP ALL Public 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CP ALL Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental drivers, CP ALL is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
DOD Biotech Public 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days DOD Biotech Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

CP ALL and DOD Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CP ALL and DOD Biotech

The main advantage of trading using opposite CP ALL and DOD Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CP ALL position performs unexpectedly, DOD Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DOD Biotech will offset losses from the drop in DOD Biotech's long position.
The idea behind CP ALL Public and DOD Biotech Public pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world